Franck Oury

Title: Franck Oury: Innovator in Cognitive Disorder Treatments

Introduction

Franck Oury is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cognitive disorders through his innovative research and patent.

Latest Patents

Oury holds a patent titled "Osteocalcin as a treatment for cognitive disorders." This patent outlines methods and compositions for treating or preventing cognitive disorders in mammals, particularly humans. The methods involve modulation of the OST-PTP signaling pathway or the PTP-1B signaling pathway, which includes gamma-carboxylase and osteocalcin. The administration of undercarboxylated or uncarboxylated osteocalcin is a key aspect of this treatment. Disorders that can be addressed by these methods include cognitive loss due to neurodegeneration associated with aging, anxiety, depression, memory loss, learning difficulties, and cognitive disorders related to food deprivation during pregnancy. Oury has 1 patent to his name.

Career Highlights

Franck Oury is affiliated with Columbia University, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential impact on treating cognitive disorders.

Collaborations

Oury collaborates with Gerard Karsenty, who is also involved in research related to cognitive disorders. Their partnership enhances the scope and depth of their work in this critical area of health.

Conclusion

Franck Oury's contributions to the treatment of cognitive disorders through his patent and research at Columbia University highlight his role as an important innovator in the field. His work has the potential to improve the lives of many individuals suffering from cognitive challenges.